Effects of Tripterygium glycosides on interleukin‑17 and CD4+CD25+CD127low regulatory T‑cell expression in the peripheral blood of patients with ankylosing spondylitis

Ji,Wei; Li,Honggang; Gao,Feng; Chen,Yajun; Zhong,Lingyu; Wang,Dan

doi:10.3892/br.2014.262

July-August 2014 Volume 2 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-August 2014 Volume 2 Issue 4

Full Size Image

Article

Effects of Tripterygium glycosides on interleukin‑17 and CD4+CD25+CD127low regulatory T‑cell expression in the peripheral blood of patients with ankylosing spondylitis

Authors:
- Wei Ji
- Honggang Li
- Feng Gao
- Yajun Chen
- Lingyu Zhong
- Dan Wang
View Affiliations / Copyright

Affiliations: Department of Rheumatism, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Emergency Department, Zhuzhou Central Hospital, Zhuzhou, Hunan 412000, P.R. China, Clinical Laboratory, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Department of Rheumatism, The First Affiliated Clinical Medical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Department of Tuberculosis, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China
Pages: 517-520
|
Published online on: March 24, 2014

https://doi.org/10.3892/br.2014.262
Expand metrics +

Abstract

The aim of this study was to investigate the possible mechanisms of action of Tripterygium glycosides (TG) in the treatment of ankylosing spondylitis (AS). In total, 20 patients with active AS received treatment with 20 mg TG tablet (TGT) 3 times per day for 6 weeks. In addition, 20 healthy age- and gender‑matched individuals were recruited as the control group. The efficacy measures included the Bath AS disease activity index (BASDAI), erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) levels. The serum interleukin (IL)‑17 levels were measured using ELISA. The expression of CD4+CD25+CD127low regulatory T cells (Tregs) in the peripheral blood was evaluated by flow cytometry. A bivariate correlation analysis was used to determine the association of IL‑17 levels with BASDAI, ESR, CRP and CD4+CD25+CD127low Tregs in AS patients. Prior to treatment, the BASDAI, ESR and CRP levels in AS patients were found to be elevated compared to those in healthy controls and were significantly reduced following TGT treatment (P<0.05, P<0.05 and P<0.05, respectively). Prior to treatment, the AS patients exhibited significantly higher IL‑17 levels compared to those in healthy controls (P<0.05). Following TGT treatment, the IL‑17 levels were significantly reduced in AS patients (P<0.01) but were not significantly different in the control subjects (P>0.05). In addition, prior to treatment, the ratio of CD4+CD25+CD127low Tregs in AS patients was significantly lower compared to that in healthy controls (P<0.05) and it was significantly increased following TGT treatment (P<0.05). The correlation analysis between the BASDAI, ESR or CRP levels and IL‑17 revealed a positive linear correlation (P<0.001, P<0.001 and P<0.01, respectively), whereas CD4+CD25+CD127low Tregs were found to be negatively correlated with IL‑17 (P<0.01). In conclusion, TGT is efficient for the treatment of AS patients and its mechanism of action may be correlated with the upregulation of CD4+CD25+CD127low Tregs and the downregulation of IL‑17 in the peripheral blood.

View Figures

View References

1	Rolle AS, Zimmermann B and Poon SH: Etanercept-induced Henoch-Schönlein purpura in a patient with ankylosing spondylitis. J Clin Rheumatol. 19:90–93. 2013.
2	Braun J and Sieper J: Ankylosing spondylitis. Lancet. 369:1379–1390. 2007. View Article : Google Scholar
3	Calin A, Brophy S and Blake D: Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet. 354:1687–1690. 1999. View Article : Google Scholar : PubMed/NCBI
4	Wendling D, Cedoz JP, Racadot E and Dumoulin G: Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine. 74:304–305. 2007. View Article : Google Scholar : PubMed/NCBI
5	Mei Y, Pan F, Gao J, et al: Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 30:269–273. 2011. View Article : Google Scholar : PubMed/NCBI
6	Wang X, Huang J, Lin Z, et al: Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatol Int. 30:955–959. 2010. View Article : Google Scholar : PubMed/NCBI
7	Davidson SI, Wu X, Liu Y, et al: Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 60:3263–3268. 2009. View Article : Google Scholar : PubMed/NCBI
8	Chen C, Zhang X, Li J and Wang Y: Associations of IL-23R polymorphisms with ankylosing spondylitis in East Asian population: a new case-control study and a meta-analysis. Int J Immunogenet. 39:126–130. 2012. View Article : Google Scholar : PubMed/NCBI
9	Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC and Sturrock RD: Ankylosing spondylitis and HL-A 27. Lancet. 1:904–907. 1973. View Article : Google Scholar : PubMed/NCBI
10	Khan MA and Ball EJ: Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol. 16:675–690. 2002. View Article : Google Scholar : PubMed/NCBI
11	Duftner C, Goldberger C, Falkenbach A, et al: Prevalence, clinical relevance and characterization of circulating cytotoxic CD4⁺CD28⁻T cells in ankylosing spondylitis. Arthritis Res Ther. 5:R292–R300. 2003. View Article : Google Scholar : PubMed/NCBI
12	Schirmer M, Goldberger C, Würzner R, et al: Circulating cytotoxic CD8⁺CD28⁻T cells in ankylosing spondylitis. Arthritis Res. 4:71–76. 2002. View Article : Google Scholar
13	van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361–368. 1984.
14	Murdaca G, Colombo BM and Puppo F: Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol. 22:557–565. 2009.PubMed/NCBI
15	Zhu S and Qian Y: IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond). 122:487–511. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wang XW, Lin ZM, Liao ZT, Wei QJ, Jiang YJ and Gu JR: The study on expression of IL-23 and IL-17 in ankylosing spondylitis. Chin J Immunol. 25:266–270. 2009.(In Chinese).
17	Wu Y, Ren M, Yang R, et al: Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4⁺CCR6⁺Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 13:R292011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Effects of Tripterygium glycosides on interleukin‑17 and CD4+CD25+CD127low regulatory T‑cell expression in the peripheral blood of patients with ankylosing spondylitis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles